gms | German Medical Science

84th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

08.05. - 12.05.2013, Nürnberg

Article

Send article

Laryngopharyngeal reflux – the unusual suspect

Meeting Abstract

Search Medline for

  • corresponding author Katya Assenova - ENT Clinic, Military Medical Academy, Sofia, Bulgaria
  • Stefan Stoyanov - Ministry of Interior, Medical Institute, Sofia, 1606, Bulgaria
  • Desislava Skerleva - Ministry of Interior, Medical Institute, Sofia, 1606, Bulgaria

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 84. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Nürnberg, 08.-12.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. Doc13hnod002

doi: 10.3205/13hnod002, urn:nbn:de:0183-13hnod0020

Published: April 15, 2013

© 2013 Assenova et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

Outline

Text

Laryngopharyngeal reflux (LPR) refers to the backflow of stomach contents into the hypopharynx and larynx. It differs from classical gastroesophageal reflux disease (GERD) in many ways. Proton pump inhibitors (PPI) have become the treatment of choice but there are significant controversies concerning their effectiveness.

Aim: To evaluate the effectiveness of PPI for treatment of LPR

Material and methods: We conducted a prospective study of 50 patients with LPR, diagnosed by reflux finding score (RFS) and reflux symptom index (RSI). We used fibrolaryngoscopy to evaluate the influence of 16 week PPI treatment on RFS and RSI.

Results: 43 patients (86%) improved after PPI treatment.

Conclusion: The reflux finding score and reflux symptom index are very helpful for diagnosing LPR. In cases where LPR is the cause of the laryngeal symptoms PPI are effective, when administered in high doses for 2–4 months.

Der Erstautor gibt keinen Interessenkonflikt an.